Efficacy of a proprietary combination of
NXT15906F6
WOMAC
joint pain
musculoskeletal functions
osteoarthritis
safety
Journal
Food & nutrition research
ISSN: 1654-661X
Titre abrégé: Food Nutr Res
Pays: Sweden
ID NLM: 101488795
Informations de publication
Date de publication:
2023
2023
Historique:
received:
05
01
2023
revised:
11
05
2023
accepted:
15
05
2023
medline:
23
6
2023
pubmed:
23
6
2023
entrez:
23
6
2023
Statut:
epublish
Résumé
NXT15906F6 (TamaFlex™) is a proprietary blend containing standardized The present randomized, double-blind, placebo-controlled study was focused on validating the clinical efficacy of NXT15906F6 in a larger number of subjects with KOA. Male and female subjects (age: 40-70 years; body mass index [BMI]: 20-29 kg/m NXT15906F6 significantly ( The anti-inflammatory botanical composition NXT15906F6 supplementation mitigated joint pain and improved musculoskeletal functions and joint motility in KOA subjects. This botanical composition was also well-tolerated by the volunteers.
Sections du résumé
Background
UNASSIGNED
NXT15906F6 (TamaFlex™) is a proprietary blend containing standardized
Objective
UNASSIGNED
The present randomized, double-blind, placebo-controlled study was focused on validating the clinical efficacy of NXT15906F6 in a larger number of subjects with KOA.
Methods
UNASSIGNED
Male and female subjects (age: 40-70 years; body mass index [BMI]: 20-29 kg/m
Results
UNASSIGNED
NXT15906F6 significantly (
Conclusion
UNASSIGNED
The anti-inflammatory botanical composition NXT15906F6 supplementation mitigated joint pain and improved musculoskeletal functions and joint motility in KOA subjects. This botanical composition was also well-tolerated by the volunteers.
Identifiants
pubmed: 37351019
doi: 10.29219/fnr.v67.9268
pii: 9268
pmc: PMC10284097
doi:
Types de publication
Journal Article
Langues
eng
Informations de copyright
© 2023 Nandlal Prasad et al.
Déclaration de conflit d'intérêts
The authors declare that there is no conflict of interest in the present research or publishing the data. Bohan & Co., Norway, and NXT USA, Inc., USA, funded the study.
Références
Phys Sportsmed. 2021 Nov;49(4):381-391
pubmed: 33554694
Int J Environ Res Public Health. 2019 Nov 26;16(23):
pubmed: 31779104
Arthritis Res Ther. 2006;8(6):R187
pubmed: 17177994
J Behav Med. 2007 Feb;30(1):77-94
pubmed: 17180640
Inflammopharmacology. 2016 Dec;24(6):377-388
pubmed: 27761693
MMWR Morb Mortal Wkly Rep. 2017 Mar 10;66(9):246-253
pubmed: 28278145
Osteoarthritis Cartilage. 2019 May;27(5):726-736
pubmed: 30391538
JAMA Netw Open. 2022 Oct 3;5(10):e2235060
pubmed: 36215072
Adv Biomed Res. 2018 Feb 28;7:38
pubmed: 29629341
Nat Rev Rheumatol. 2019 Jan;15(1):49-60
pubmed: 30523334
Biorheology. 2002;39(1-2):237-46
pubmed: 12082286
Front Biosci. 2006 Jan 01;11:529-43
pubmed: 16146751
Ther Adv Musculoskelet Dis. 2022 Sep 22;14:1759720X221124545
pubmed: 36171802
Pain. 1985 May;22(1):1-31
pubmed: 4011282
Foods. 2017 Oct 22;6(10):
pubmed: 29065496
J Rheumatol. 1988 Dec;15(12):1833-40
pubmed: 3068365
Food Funct. 2014 Mar;5(3):587-97
pubmed: 24500568
Oxid Med Cell Longev. 2022 Jan 07;2022:6887988
pubmed: 35035664
Vet Med Sci. 2022 Sep;8(5):1936-1945
pubmed: 35905197
Ann Rheum Dis. 2014 Jul;73(7):1369-75
pubmed: 23716068
Res Q Exerc Sport. 1999 Jun;70(2):113-9
pubmed: 10380242
Ann Rheum Dis. 1957 Dec;16(4):494-502
pubmed: 13498604
Life Sci. 2019 Oct 1;234:116786
pubmed: 31445934
Int J Med Sci. 2019 Jun 2;16(6):845-853
pubmed: 31337958
Pharmacol Res. 2016 Sep;111:394-404
pubmed: 27392742
Arthritis Rheum. 2001 Jun;44(6):1237-47
pubmed: 11407681
Cartilage. 2021 Dec;13(2_suppl):153S-167S
pubmed: 34474599
Curr Rheumatol Rev. 2020;16(2):158-164
pubmed: 31868149
Sci Rep. 2015 Jun 10;5:11117
pubmed: 26059174
Rheum Dis Clin North Am. 2008 Aug;34(3):623-43
pubmed: 18687276
Drug Dev Res. 2019 May;80(3):353-359
pubmed: 30663793
Expert Opin Pharmacother. 2020 May;21(7):797-809
pubmed: 32100600
J Am Nutr Assoc. 2023 May 24;:1-11
pubmed: 37224433
Evid Based Complement Alternat Med. 2022 Jan 19;2022:2226139
pubmed: 35096104